|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Physiology and Morphology, Hoshi University, Tokyo, Shinagawa-ku, Japan
2 Physiology and Morphology, Hoshi University, Tokyo, Shinagawa-ku, Japan; Physiology and Morphology, Hoshi Univeristy, Tokyo, Shinagawa-ku, Japan
* To whom correspondence should be addressed. E-mail: kamata{at}hoshi.ac.jp.
We investigated whether the balance between endothelium-derived relaxing factors (EDRFs) and endothelium-derived contracting factors (EDCFs) might be altered in mesenteric arteries from aged Otsuka Long-Evans Tokushima Fatty rats (OLETF) (a type 2 diabetic model) [vs. age-matched control Long-Evans Tokushima Otsuka rats (LETO)]. ACh-induced relaxation was impaired in the OLETF group and a tendency for the relaxation to reverse at high ACh concentrations was observed in both groups. This tendency was abolished by indomethacin. The NO- and/or EDHF-mediated relaxation, and the protein expressions of phospho-eNOS (Ser1177) and extracellular superoxide dismutase were also reduced in OLETF. An ACh-induced contraction was observed at higher ACh concentrations in the presence of NG-nitro-L-arginine (L-NNA), but was greater in OLETF. This contraction in OLETF was reduced by cyclooxygenase (COX) inhibitors and by prostanoid-receptor antagonists. The ACh-induced productions of TXA2 and PGE2 were greater in OLETF than in LETO, as were the mesenteric artery COX-1 and COX-2 protein expressions. Moreover, tert-butyl hydroperoxide (t-BOOH) (membrane-permeant oxidant) induced a concentration-dependent contraction that was greater in OLETF. The t-BOOH-mediated contraction was increased both by L-NNA and by endothelium removal in LETO, but not in OLETF, suggesting that a negative modulatory role of the endothelium was lost in OLETF. These results suggest that an imbalance between EDRFs and EDCFs may be implicated in the endothelial dysfunction seen in aged OLETF mesenteric arteries, and may be attributable to increased oxidative stress.
This article has been cited by other articles:
![]() |
T. Matsumoto, K. Ishida, N. Nakayama, T. Kobayashi, and K. Kamata Involvement of NO and MEK/ERK pathway in enhancement of endothelin-1-induced mesenteric artery contraction in later-stage type 2 diabetic Goto-Kakizaki rat Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1388 - H1397. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Matsumoto, N. Nakayama, K. Ishida, T. Kobayashi, and K. Kamata Eicosapentaenoic Acid Improves Imbalance between Vasodilator and Vasoconstrictor Actions of Endothelium-Derived Factors in Mesenteric Arteries from Rats at Chronic Stage of Type 2 Diabetes J. Pharmacol. Exp. Ther., April 1, 2009; 329(1): 324 - 334. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Schror Cyclooxygenase-2-Derived Prostaglandin F2{alpha}: An Endothelium-Derived Contractile Factor Acting Independently of Other Endothelium-Derived Contractile Factors via Vascular Thromboxane Receptors Circ. Res., January 30, 2009; 104(2): 141 - 143. [Full Text] [PDF] |
||||
![]() |
T. Matsumoto, E. Noguchi, K. Ishida, T. Kobayashi, N. Yamada, and K. Kamata Metformin normalizes endothelial function by suppressing vasoconstrictor prostanoids in mesenteric arteries from OLETF rats, a model of type 2 diabetes Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1165 - H1176. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |